Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
01 1Supriya Lifescience Limited
02 1Fagron Inc
03 1HIKAL LIMITED
04 1Kalchem International inc
05 1LETCO MEDICAL, LLC
06 1Medisca Inc.
07 1Olon S.p.A.
08 1Professional Compounding Centers of America
09 1Professional Compounding Centers of America dba PCCA
10 1SUN PHARMACEUTICAL INDUSTRIES, INC.
01 5PENTOXIFYLLINE
02 4Pentoxifylline
03 1Pentoxifyllline
01 3India
02 1Italy
03 1Netherlands
04 3U.S.A
05 2United Kingdom
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-3500
Start Marketing Date : 2016-11-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1059
Start Marketing Date : 2004-09-01
End Marketing Date : 2026-05-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66651-912
Start Marketing Date : 2015-08-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-432
Start Marketing Date : 2022-07-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2521
Start Marketing Date : 2010-12-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2560
Start Marketing Date : 2012-04-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17337-0426
Start Marketing Date : 2017-12-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-4389
Start Marketing Date : 2009-07-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0310
Start Marketing Date : 2023-08-14
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62756-117
Start Marketing Date : 2021-01-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
50
PharmaCompass offers a list of Pentoxifylline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pentoxifylline manufacturer or Pentoxifylline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pentoxifylline manufacturer or Pentoxifylline supplier.
PharmaCompass also assists you with knowing the Pentoxifylline API Price utilized in the formulation of products. Pentoxifylline API Price is not always fixed or binding as the Pentoxifylline Price is obtained through a variety of data sources. The Pentoxifylline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Angiopent manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Angiopent, including repackagers and relabelers. The FDA regulates Angiopent manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Angiopent API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Angiopent manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Angiopent supplier is an individual or a company that provides Angiopent active pharmaceutical ingredient (API) or Angiopent finished formulations upon request. The Angiopent suppliers may include Angiopent API manufacturers, exporters, distributors and traders.
click here to find a list of Angiopent suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Angiopent as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Angiopent API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Angiopent as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Angiopent and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Angiopent NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Angiopent suppliers with NDC on PharmaCompass.
We have 9 companies offering Angiopent
Get in contact with the supplier of your choice:
